Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer

• Published in: Radiation oncology (London, England) England), 2019-10, Vol.14 (1), p.181-181, Article 181
• Main Authors: Xu, Yiyue, Wang, Linlin, He, Bo, Li, Wanlong, Wen, Qiang, Wang, Shijiang, Sun, Xindong, Meng, Xue, Yu, Jinming
• Format: Article
• Language: English
• Subjects: Analysis; Cancer patients; Cancer research; Care and treatment; Case-Control Studies; Chemoradiotherapy - adverse effects; Diatrizoate; Esophageal cancer; Esophageal fistula; Esophageal Fistula - diagnosis; Esophageal Fistula - etiology; Esophageal Neoplasms - pathology; Esophageal Neoplasms - therapy; Female; Fistulas; Health risk assessment; Humans; Male; Marriage; Marriage and sex; Middle Aged; Nomogram; Nomograms; Prognosis; Radiotherapy; Retrospective Studies; Risk Factors; ROC Curve; Venture capital
• ISSN: 1748-717X; 1748-717X
• DOI: 10.1186/s13014-019-1385-y

We aimed to identify the risk factors and provide a nomogram for the prediction of radiotherapy-related esophageal fistula in patients with esophageal cancer (EC) using a case-control study. Patients with esophageal fistula who received radiotherapy or chemoradiotherapy between 2003 and 2017 were retrospectively collected in two institutions. In the training cohort (TC), clinical, pathologic, and serum data of 136 patients (cases) who developed esophageal fistula during or after radiotherapy were enrolled and compared with 272 controls (1:2 matched with the diagnosis time of EC, sex, marriage, and race). After the univariable and multivariable logistic regression analyses, the independent risk factors were identified and incorporated into a nomogram. Then the nomogram for the risk prediction was externally validated in the validation cohort (VC; 47 cases and 94 controls) using bootstrap resampling. Multivariable analyses demonstrated that ECOG PS, BMI, T4, N2/3 and re-radiotherapy were independent factors for esophageal fistula. Then a nomogram was constructed with the C-index of 0.805 (95% CI, 0.762-0.848) for predicting the risk of developing esophageal fistula in EC patients receiving radiotherapy. Importantly, the C-index maintained 0.764 (95% CI, 0.683-0.845) after the external validation. We created and externally validated the first risk nomogram of esophageal fistula associated with radiotherapy. This will aid individual risk stratification of patients with EC developing esophageal fistula.